PMID- 33202885
OWN - NLM
STAT- MEDLINE
DCOM- 20210514
LR  - 20210514
IS  - 1648-9144 (Electronic)
IS  - 1010-660X (Print)
IS  - 1010-660X (Linking)
VI  - 56
IP  - 11
DP  - 2020 Nov 13
TI  - Vertical Bone Gain after Sinus Lift Procedures with Beta-Tricalcium Phosphate and 
      Simultaneous Implant Placement-A Cross-Sectional Study.
LID - 10.3390/medicina56110609 [doi]
LID - 609
AB  - OBJECTIVES: The objective of this cross-sectional study was to evaluate the 
      vertical bone gain achieved after the sinus lift procedure with beta-tricalcium 
      phosphate (beta-TCP) used as a bone substitute and simultaneous implant placement. 
      METHODS: One hundred and twenty-eight sinus lift procedures (utilizing a 
      synthetic ceramic containing 99.9% tricalcium phosphate as a bone substitute) and 
      simultaneous implant placements were performed on 119 patients. The lateral 
      window approach surgical protocol for maxillary sinus lift was performed on the 
      patients. The implants were evaluated using cone-beam computed tomography (CBCT) 
      at 6 months following placement. The vertical bone gain was considered a primary 
      variable, while implant length, diameter, and location were considered secondary 
      variables. RESULTS: The ANOVA results showed no statistical difference in 
      vertical bone gain with implant parameters like implant length, width, and 
      position. Pearsons correlation revealed a statistically significant positive 
      correlation with vertical bone gain and implant length and diameter. A further 
      multivariate linear regression analysis was performed and it observed 
      statistically significant associations between the variables in the study after 
      adjusting for confounding factors. CONCLUSIONS: This study concluded that there 
      was vertical bone gain with the usage of beta-TCP in maxillary sinus lift surgical 
      procedure with immediate implant placement and that implant variables like length 
      and diameter had a significant influence on the average bone gain values. The 
      implant position did not have a statistically significant influence but there was 
      considerable variation in the bone gain between first, second premolar, and molar 
      regions.
FAU - Aragoneses Lamas, Juan Manuel
AU  - Aragoneses Lamas JM
AD  - Department of Dental Research, Federico Henriquez y Carvajal University, Santo 
      Domingo 10106, Dominican Republic.
FAU - Sanchez, Margarita Gomez
AU  - Sanchez MG
AD  - Department of Dentistry, Universidad Europea de Madrid, 28670 Madrid, Spain.
FAU - Gonzalez, Levi Cuadrado
AU  - Gonzalez LC
AD  - Department of Implantology and Regeneration, Universidad de Vic-Universidad 
      Central de Cataluna, 08500 Barcelona, Spain.
FAU - Suarez Garcia, Ana
AU  - Suarez Garcia A
AUID- ORCID: 0000-0003-2448-6669
AD  - Department of Pre-clinical Dentistry, Universidad Europea de Madrid, 28670 
      Madrid, Spain.
FAU - Aragoneses Sanchez, Javier
AU  - Aragoneses Sanchez J
AUID- ORCID: 0000-0002-6373-0233
AD  - Department of Dental Research, Federico Henriquez y Carvajal University, Santo 
      Domingo 10106, Dominican Republic.
LA  - eng
PT  - Journal Article
DEP - 20201113
PL  - Switzerland
TA  - Medicina (Kaunas)
JT  - Medicina (Kaunas, Lithuania)
JID - 9425208
RN  - 0 (Bone Substitutes)
RN  - 0 (Calcium Phosphates)
RN  - 0 (beta-tricalcium phosphate)
SB  - IM
MH  - *Bone Substitutes
MH  - Calcium Phosphates
MH  - Cross-Sectional Studies
MH  - Humans
MH  - Maxilla/diagnostic imaging/surgery
MH  - *Maxillary Sinus/diagnostic imaging/surgery
PMC - PMC7697819
OTO - NOTNLM
OT  - beta-tricalcium phosphate
OT  - bone regeneration
OT  - dental implant
OT  - maxillary sinus lift
OT  - vertical bone gain
COIS- The authors certify that they have no affiliations with or involvement in any 
      organization or entity with any financial interest (such as honoraria; 
      educational grants; participation in speakers' bureaus; membership, employment, 
      consultancies, stock ownership, or other equity interest; and expert testimony or 
      patent-licensing arrangements), or non-financial interest (such as personal or 
      professional relationships, affiliations, knowledge or beliefs) in the subject 
      matter or materials discussed in this manuscript.
EDAT- 2020/11/19 06:00
MHDA- 2021/05/15 06:00
PMCR- 2020/11/13
CRDT- 2020/11/18 01:01
PHST- 2020/10/17 00:00 [received]
PHST- 2020/11/01 00:00 [revised]
PHST- 2020/11/11 00:00 [accepted]
PHST- 2020/11/18 01:01 [entrez]
PHST- 2020/11/19 06:00 [pubmed]
PHST- 2021/05/15 06:00 [medline]
PHST- 2020/11/13 00:00 [pmc-release]
AID - medicina56110609 [pii]
AID - medicina-56-00609 [pii]
AID - 10.3390/medicina56110609 [doi]
PST - epublish
SO  - Medicina (Kaunas). 2020 Nov 13;56(11):609. doi: 10.3390/medicina56110609.